leadf
logo-loader
TSX:VLNS OTCQX:VLNCF

The Valens Company

Receive alerts
Market:
TSX
Market Cap:
$441.97 m
Price
2.55 CAD
Change
-4.49%
52 weeks high
4.00
52 weeks low
1.44

In brief

The Valens Company is a leading manufacturer of cannabis derivative products with a mission to bring the benefits of cannabis to the world. It provides proprietary cannabis processing services across five core technologies, in addition to best-in-class product development, formulation and manufacturing of cannabis consumer packaged goods. The company's high-quality products are exclusively formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on next-generation product development and innovation. Its breakthrough patented emulsification technology, SōRSE by Valens, converts cannabis oil into water-soluble emulsions for seamless integration into a variety of product formats, allowing for near-perfect dosing, stability, and taste. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, the company continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences in key markets. Through its wholly-owned subsidiary Valens Labs Ltd., the company is setting the standard in cannabis testing and research and development with Canada's only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific.

Snapshot

  • The Valens Company announces strategic distribution agreement with APOTEKA, provides Australia update
  • The Valens Company receives ‘positive’ buy rating from Stifel following two acquisitions
  • The Valens Company take a large chunk of market share after acquisition of Verse and Citizen Stash